InvestWiser

Flerie

FLERIENasdaq StockholmHealthcareMarket value 1.2 bn SEK
13.10SEK +1.6%
last day · Price as of 18 November 2026

The answer first

Does Flerie beat the market?

No, Flerie has not beaten the market over the last year.

Flerie−59.8%Stockholm (OMXSGI)+18.4%
  • The ranking · Quality, value and trend combined

    Better than 3% of Nordic stocks

    • Quality27
    • Value21
    • Trend6

    No. 181 of 195 in healthcare

Max for seven days

Follow Flerie with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Flerie

From today, at a price of 13.10 SEK. Write why you follow Flerie, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Flerie

Your first answer is free, no account needed.

Do you own Flerie, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Flerie and a few more. Free, no card.

Past year against the exchange and Super Stock
Flerie−59.8%Stockholm (OMXSGI)+18.4%Super Stock+45.9%
17 November 202518 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Flerie has fallen 59.8% over the past year, including dividends.
  • Overall, Flerie ranks better than 3% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 74.2%. The price is 73.2% below its peak now.

What do analysts think of Flerie?

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

3

Quality, value and trend together. Better than 3% of Nordic stocks.

No. 181 of 195 in healthcare

Quality27
The company · Fundamentals: the accounts

Low Weaker accounts than most: low profitability, high debt or uneven results.

No. 161 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity0.00
  • Asset turnoverSales divided by everything the company owns0.00
  • Return on equityProfit divided by equity−31.3%
  • Cash conversionOperating cash flow divided by profit–

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value21
The price · Valuation: the multiples

Low High price: buyers pay a lot today, often because they expect growth.

No. 97 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50

  • P/BPrice divided by equity0.4
  • P/SPrice divided by salesnegative earnings
  • P/EPrice divided by earningsnegative earnings
  • P/CFPrice divided by operating cash flownegative earnings

The ranking is built on P/E, P/B and P/S.

Trend6
The share price · Technical: the price trend

Low Headwind in the share price: it has done worse than most over the last year.

No. 168 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months−33.5%
  • 6 months−44.7%
  • 9 months−56.5%
  • 12 months−59.8%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
−12.1%
3 years, per year
+1,050.6%
5 years, per year
+278.8%
10 years, per year
+86.5%
Largest fall, 3 years
−74.2%
From a peak to the bottom
From the peak now
−73.2%
How far the price is from the peak
Volatility, 1 year
33.6%
How much the price swings over a year
Beta, 1 year
−0.14
How much the price moves when the market moves

Return with dividends reinvested.

The funds that own Flerie

2 funds we follow own Flerie. The share is how much of the fund the stock makes up.

  • Sweden2

From the funds' latest known holdings.

About Flerie

Flerie is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 8 employees.

Flerie AB (publ) is a venture capital firm specializing in early-stage investments. The firm seeks to invest in life science, biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, Nordic, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm, Sweden with additional office in London, United Kingdom.

See the full analysis of Flerie.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Nasdaq Stockholm

Explore the stock market